Auxeris Therapeutics
Closed- Headquarters
- St. Louis, Missouri
- Business Model
- B2B
About
Auxeris Therapeutics, Inc. was a St. Louis, Missouri-based biopharmaceutical company focused on developing non-destructive, disease-modifying treatments for osteoporosis and other bone diseases. Backed by venture investors including Domain Associates, the company built a pipeline of bone-disease therapeutics before merging with Tranzyme, Inc.; the combined company was renamed Ocera Therapeutics, Inc.
Summary
Auxeris Therapeutics is a Biotech company based in St. Louis, United States.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/auxeris-therapeutics"><img src="https://indexed.vc/api/badge/company/auxeris-therapeutics" alt="Auxeris Therapeutics on Indexed.vc" width="260" height="76" /></a>